Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Teva | Partnership | Direct Relief
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
End Of Schultz Era Looms For Teva :: Generics Bulletin
Teva Proposes $5B Settlement for Thousands of Opioid Lawsuits | BioSpace
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
IP finance: When a company's future is caught in the generic drug/proprietary drug crosshairs
Teva Pharmaceuticals Q4 2016 Earnings
Teva shares approach 20-year low amid Moody's warning and other woes | Fierce Pharma
Teva exits Massachusetts as Cambridge site falls victim to restructuring - Boston Business Journal
Teva Pharmaceuticals on Twitter: "Teva Global Operations NA and Complex Manufacturing Finance Leader Mayra Avila shares how she confronted a challenge head-on to find her voice. Read her story and learn more
Generic Versions Of Copaxone Take Toll On Teva 3Q Results - Drug Discovery and Development